| P50 | author | Michel Bourin | Q114436140 |
| P2093 | author name string | Florence Thibaut | |
| P2860 | cites work | Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder | Q22242334 |
| | Haloperidol alone or in combination for acute mania | Q24245158 |
| | Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis | Q28245879 |
| | Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group | Q28375949 |
| | The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 |
| | A New Depression Scale Designed to be Sensitive to Change | Q29614720 |
| | A rating scale for mania: reliability, validity and sensitivity | Q29619299 |
| | Anticipation of increasing monetary reward selectively recruits nucleus accumbens | Q29619743 |
| | Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). | Q31951593 |
| | Increases in manic symptoms after life events involving goal attainment | Q33761315 |
| | Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia | Q33876496 |
| | A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders | Q33927263 |
| | Bipolarity from ancient to modern times: conception, birth and rebirth | Q33957680 |
| | New treatment guidelines for acute bipolar mania: a critical review | Q34234224 |
| | A diagnostic interview: the schedule for affective disorders and schizophrenia | Q34269355 |
| | The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania | Q34606256 |
| | Clinical practice recommendations for bipolar disorder | Q34606360 |
| | Valproate in the treatment of acute mania. A placebo-controlled study | Q34613045 |
| | Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group | Q34727272 |
| | Can personality traits predict increases in manic and depressive symptoms? | Q35107654 |
| | Psychological treatment for bipolar disorders--a review of randomised controlled trials. | Q35775027 |
| | Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials | Q36466463 |
| | Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials | Q36936379 |
| | Magnitude of effect of lithium in short-term efficacy studies of moderate to severe manic episode | Q37030962 |
| | Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology | Q37426143 |
| | Asenapine | Q37581589 |
| | New treatment guidelines for acute bipolar depression: a systematic review | Q37764207 |
| | Asenapine: a review of its use in the management of mania in adults with bipolar I disorder | Q37842439 |
| | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry | Q38012647 |
| | A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania. | Q38402146 |
| | Carbamazepine treatment of mania: clinical and biochemical aspects | Q41364090 |
| | Risperidone plus lithium versus risperidone plus valproate in acute and continuation treatment of mania | Q42624547 |
| | Lamotrigine compared with lithium in mania: a double-blind randomized controlled trial | Q42625897 |
| | Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder | Q42629774 |
| | Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group | Q43507067 |
| | Pattern of response to divalproex, lithium, or placebo in four naturalistic subtypes of mania | Q43942949 |
| | Olanzapine versus divalproex in the treatment of acute mania | Q44013092 |
| | Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety | Q44045819 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. | Q44142664 |
| | A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder | Q44275529 |
| | Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial | Q44299951 |
| | A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania | Q44565868 |
| | A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania | Q44684784 |
| | Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study | Q44874572 |
| | A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes. | Q44877765 |
| | A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder | Q45237779 |
| | Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. | Q45484599 |
| | Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice. | Q46027622 |
| | Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial. | Q46377270 |
| | Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial | Q46681464 |
| | Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial | Q46683979 |
| | Olanzapine monotherapy and olanzapine combination therapy in the treatment of mania: 12-week results from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) observational study | Q47777106 |
| | Asenapine as adjunctive treatment for acute mania associated with bipolar disorder: results of a 12-week core study and 40-week extension | Q48774724 |
| | 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery. | Q50557650 |
| | Depression during mania. Treatment response to lithium or divalproex. | Q50978467 |
| | Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial. | Q51903227 |
| | Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. | Q52058150 |
| | Quetiapine for treatment-resistant mania. | Q54043314 |
| | Why Do Clinicians Maintain Antidepressants in Some Patients With Acute Mania? | Q57612596 |
| | Risperidone compared with both lithium and haloperidol in mania: a double-blind randomized controlled trial | Q59210536 |
| | Carbamazepine compared with lithium in the treatment of mania | Q68027502 |
| | Risperidone in the treatment of mania | Q71151091 |
| | Short-term variability of mood ratings in unipolar and bipolar depressed patients | Q71567635 |
| | Lithium compared to valproic acid and carbamazepine in the treatment of mania: a statistical meta-analysis | Q71703609 |
| | Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders | Q71742954 |
| | [Neuropsychotropic action of a new anti-epileptic agent: depamide] | Q72858678 |
| | Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients | Q73425839 |
| | Generalisability of results from randomised drug trials. A trial on antimanic treatment | Q73523056 |
| | Diagnostic depressive symptoms of the mixed bipolar episode | Q73820828 |
| | Long-term risperidone treatment in bipolar disorder: 6-month follow up | Q74453983 |
| P304 | page(s) | 4 | |
| P577 | publication date | 2013-01-29 | |
| P1433 | published in | Frontiers in Pharmacology | Q2681208 |
| P1476 | title | How assess drugs in the treatment of acute bipolar mania? | |
| P478 | volume | 4 | |